| 产品编号 |
英文名称 |
CAS号 |
产品规格 |
价格 |
货期 |
| ZMR-44-0778 |
(1-(2,6-Diethylphenyl)-3,5,5-trimethyl-3-phenylpyrrolidin-2-ylidene)(2-isopropoxy-5-nitrobenzylidene)ruthenium(II) dichloride UltraNitroCat |
[2106819-64-9] |
100mg |
咨询 |
3-5周 |
| ZMR-15-5130 |
(11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu |
[213843-90-4] |
100mg |
咨询 |
3-5周 |
| ZMR-15-5184 |
(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP |
[856407-37-9] |
100mg |
咨询 |
1-3天 |
| ZMR-15-5162 |
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (R)-SIPHOS-PE |
[500997-69-3] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8566 |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-8572 |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0377 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1297613-73-0] |
50mg |
咨询 |
3-5周 |
| ZMR-15-2190 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg] [1,3,2]dioxaphosphocin, 98% (99% ee) |
[1297613-74-1] |
50mg |
咨询 |
3-5周 |
| ZMR-15-1363 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98% |
[1372719-93-1] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0334 |
(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1345628-08-1] |
25mg |
咨询 |
3-5周 |
| ZMR-15-2170 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg] [1,3,2]dioxaphosphocin, 98% (99% ee) |
[1297613-72-9] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0293 |
(11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1297613-77-4] |
25mg |
咨询 |
3-5周 |
| ZMR-15-0574 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95% (99% ee) |
[1372719-95-3] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8596 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% |
N/A |
10mg |
咨询 |
3-5周 |
| ZMR-15-5965 |
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99%) |
[1352810-35-5] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8588 |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-8569 |
(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0484 |
(11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0494 |
(11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0576 |
(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95% (99% ee) |
[1352810-37-7] |
50mg |
咨询 |
3-5周 |
| ZMR-15-8578 |
(11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0339 |
(11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-0277 |
(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee) |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-0538 |
(11aR)-3,7-Bis(2,4,6-trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
[1801196-27-9] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0514 |
(11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8562 |
(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0542 |
(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98% |
[1297613-75-2] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8575 |
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0276 |
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8584 |
(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0526 |
(11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
[1352810-38-8] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0520 |
(11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
[1372719-94-2] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0527 |
(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98% |
[1297613-76-3] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0532 |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-8592 |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0571 |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-0565 |
(11aR)-3,7-Bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95% |
N/A |
25mg |
咨询 |
3-5周 |
| ZMR-15-0546 |
(11aR)-3,7-Bis[4-(2-naphthalenyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-5157 |
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP |
[885701-71-3] |
100mg |
咨询 |
3-5周 |
| ZMR-15-5163 |
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (S)-SIPHOS-PE |
[500997-70-6] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0544 |
(11aS)-)-3,7-Bis(2,4,6-trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0530 |
(11aS)-)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0557 |
(11aS)-1,2,10,11-Tetramethyl-4,8-bis(t-butyl)-6-[[(2S,5S)-(2,5-diphenyl-1-phospholanyl) methoxy]-dibenzo[d,f][1,3,2]dioxaphosphepin] SaxS,S-BOBPHOS |
[1373349-83-7] |
100mg |
咨询 |
3-5周 |
| ZMR-15-8567 |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-8573 |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-2185 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg] [1,3,2]dioxaphosphocin 98% (99% ee) |
[1258327-08-0] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0290 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-1364 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98% |
[1585988-92-6] |
100mg |
咨询 |
3-5周 |
| ZMR-15-2171 |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg] [1,3,2]dioxaphosphocin, 98% (99% ee) |
[1258327-04-6] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0294 |
(11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee) |
[1258327-06-8] |
25mg |
咨询 |
3-5周 |
